This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Plant Health Care Valuation

Q: What is the Fair Price of PLHC.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

PLHC.F ($0.15) is trading below our estimate of [[fair value]] ($0.4)

Is PLHC.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of PLHC.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: PLHC.F ($0.15) is trading below our estimate of fair value ($0.4)

Significantly Below Fair Value: PLHC.F is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for PLHC.F?

Key metric: As PLHC.F is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for PLHC.F. This is calculated by dividing PLHC.F's market cap by their current revenue.
What is PLHC.F's PS Ratio?
PS Ratio	3.5x
Sales	US$11.21m
Market Cap	US$39.73m

PLHC.F key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	3.5x
Enterprise Value/EBITDA	-8.9x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does PLHC.F's PS Ratio compare to its peers?

The above table shows the PS ratio for PLHC.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	2.2x
MULG Muliang Viagoo Technology	4.1x	n/a	US$49.1m
ENFY Enlightify	0.3x	n/a	US$25.9m
AVD American Vanguard	0.3x	4.8%	US$173.0m
KNGW Kenongwo Group US	4.2x	n/a	US$32.6m
PLHC.F Plant Health Care	3.5x	35.8%	US$30.5m

Price-To-Sales vs Peers: PLHC.F is expensive based on its Price-To-Sales Ratio (3.5x) compared to the peer average (1.5x).

Price to Sales Ratio vs Industry

How does PLHC.F's PS Ratio compare vs other companies in the US Chemicals Industry?

12 Companies	Price / Sales	Estimated Growth	Market Cap
TSE Trinseo	0.04x	4.1%	US$153.29m
ALTO Alto Ingredients	0.1x	3.1%	US$111.14m
ENFY Enlightify	0.3x	n/a	US$25.89m
BON Bon Natural Life	0.2x	n/a	US$6.35m

12 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: PLHC.F is expensive based on its Price-To-Sales Ratio (3.5x) compared to the US Chemicals industry average (1.4x).

Price to Sales Ratio vs Fair Ratio

What is PLHC.F's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PLHC.F PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	3.5x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate PLHC.F's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Huntsman

US$3.4b

Manufactures and sells diversified organic chemical products worldwide.

HUN

US$19.58

-0.8%

-21.8%

CMOC Group

HK$159.3b

Engages in the mining, beneficiation, smelting, and refining of base and rare metals.

CMCL.F

HK$0.70

-9.4%

27.9%

Mativ Holdings

US$714.5m

Manufactures and sells specialty materials in the United States, Europe, the Asia Pacific, the Americas, and internationally.

MATV

US$13.15

-0.3%

-4.1%